John Brendan Doyle - 18 Dec 2025 Form 4 Insider Report for COGNITION THERAPEUTICS INC (CGTX)

Role
Chief Financial Officer
Signature
/s/ John Brendan Doyle
Issuer symbol
CGTX
Transactions as of
18 Dec 2025
Net transactions value
-$14,040
Form type
4
Filing time
22 Dec 2025, 16:10:23 UTC
Previous filing
31 Jul 2025
Next filing
05 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Doyle John Brendan Chief Financial Officer C/O COGNITION THERAPEUTICS INC, 2500 WESTCHESTER AVE., PURCHASE /s/ John Brendan Doyle 22 Dec 2025 0001840738

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CGTX Common Stock Award $0 +30,000 +7.1% $0.000000 455,350 18 Dec 2025 Direct F1
transaction CGTX Common Stock Tax liability $14,040 -9,360 -2.1% $1.50 445,990 18 Dec 2025 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares earned upon the vesting of performance stock units ("PSUs") granted to the Reporting Person on February 14, 2024. Each PSU represents a contingent right to receive one share of the Issuer's Common Stock upon the achievement of certain performance goals. The remaining 50% of the total number of shares subject to the PSUs vested on December 18, 2025.
F2 Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of PSUs.